- Our experts in male sexual dysfunction have vast expertise in treating Peyronie’s disease.
- We are one of the main referral centers in the Northeast for treatment of Peyronie’s disease
- We personalize care to the patient, offering all treatments including medication and precision surgical reconstruction.
- Yale Medicine participated in the clinical trials that led to the first approved drug to treat the condition.
An injury to the penis isn’t something most men want to think about, but it can happen, potentially causing curvature and shortening of the penis. This condition is called Peyronie’s disease, and it can make intercourse difficult or impossible, says Stanton Honig, MD, a urologic surgeon who heads Yale Medicine’s Male Sexual Medicine and Male Reproductive Health programs.
Although Peyronie’s disease isn’t a widely known condition, it is more common than you might guess, affecting about 1 in 11 men.
Until recently, surgery was the only effective treatment for Peyronie’s disease. Dr. Honig participated in clinical trials for the first drug approved by the Food and Drug Administration (FDA) for treatment of Peyrone’s disease, collaganese (brand name: Xiaflex). “I think the fact that we have an FDA-approved drug is really a breakthrough in this disease,” he says.